©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 344-354
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.344
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.344
Table 2 Criteria for unresectability[15]
| Patient factors |
| Medically unfit or otherwise unable to tolerate a major operation |
| Hepatic cirrhosis |
| Local tumor-related factors |
| Tumor extension to secondary biliary radicles bilaterally |
| Encasement or occlusion of the main portal vein proximal to its bifurcation |
| Atrophy of one hepatic lobe with contralateral portal vein branch encasement or occlusion |
| Atrophy of one hepatic lobe with contralateral tumor extension to secondary biliary radicles |
| Unilateral tumor extension to secondary biliary radicles with contralateral portal vein branch |
| encasement or occlusion |
| Metastatic disease |
| Histologically proven metastases to N2 lymph nodes1 |
| Lung, liver, or peritoneal metastases |
- Citation: Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354
- URL: https://www.wjgnet.com/2150-5330/full/v5/i3/344.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v5.i3.344